MPTP

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

1997 • 7,814 citations

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

1983 • 4,822 citations

BCL-2 family members and the mitochondria in apoptosis

1999 • 3,657 citations

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

2000 • 3,559 citations

Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β

2000 • 3,241 citations

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

1973 • 2,615 citations

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1983 • 2,149 citations

Mitochondrial Complex I Deficiency in Parkinson's Disease

1990 • 2,147 citations

Recent Developments in Parkinson's Disease

1987 • 1,790 citations

MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE

1989 • 1,717 citations

An Essay on the Shaking Palsy

2002 • 1,658 citations

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1979 • 1,356 citations

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

1985 • 1,253 citations

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1985 • 1,236 citations

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

2001 • 1,210 citations

Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine

2000 • 1,112 citations

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

1984 • 1,092 citations

Abnormalities of the electron transport chain in idiopathic parkinson's disease

1989 • 1,067 citations

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

1999 • 1,035 citations

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1984 • 1,007 citations

Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice

1984 • 1,005 citations

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1999 • 967 citations

Parkinson Disease in Twins<SUBTITLE>An Etiologic Study</SUBTITLE>

1999 • 861 citations

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

2001 • 775 citations

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

1984 • 772 citations

Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease

2000 • 755 citations

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women

2001 • 659 citations

The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice

2002 • 644 citations

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

1996 • 626 citations

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1991 • 554 citations

Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds

1993 • 541 citations

Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis

1991 • 518 citations

Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson's Disease Mutation

1998 • 510 citations

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

2001 • 507 citations

In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining

1997 • 460 citations

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

1992 • 457 citations

Environmental Risk Factors and Parkinson's Disease: A Metaanalysis

2001 • 435 citations

Neuroprotection by Caffeine and A_2AAdenosine Receptor Inactivation in a Model of Parkinson's Disease

2001 • 424 citations

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

1992 • 423 citations

Inhibition of Neuronal Nitric Oxide Synthase by 7‐Nitroindazole Protects Against MPTP‐Induced Neurotoxicity in Mice

1995 • 416 citations

Degradation of α-Synuclein by Proteasome

1999 • 406 citations

Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1998 • 406 citations

Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.

1986 • 404 citations

NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults

1994 • 402 citations

FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

1999 • 401 citations

Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization

1989 • 388 citations

Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System

1998 • 384 citations

Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells

1998 • 382 citations

α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP

2000 • 379 citations

Complex I Inhibitors Induce Dose‐Dependent Apoptosis in PC12 Cells: Relevance to Parkinson's Disease

1994 • 365 citations

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

2001 • 360 citations

Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys

1986 • 347 citations

FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,In Vitro,Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells

1999 • 335 citations

Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo

2000 • 332 citations

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset

1984 • 324 citations

Differential expression of two vesicular monoamine transporters

1995 • 319 citations

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

1996 • 312 citations

Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis

1992 • 308 citations

The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism

1999 • 304 citations

Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease

2000 • 303 citations

MPTP

1986 • 293 citations

Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity

1985 • 290 citations

Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP ⁺ Binds to Neuromelanin

1986 • 289 citations

MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons

2000 • 277 citations

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

1998 • 277 citations

Increased susceptibility to sporadic Parkinson's disease by a certain combined ?-synuclein/apolipoprotein E genotype

1999 • 271 citations

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

1994 • 270 citations

Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+

1986 • 267 citations

Caspase-8 Is an Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease, But Pathway Inhibition Results in Neuronal Necrosis

2001 • 265 citations

Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism

1986 • 250 citations

Antiparkinsonian effect of a new selective adenosine A _2A receptor antagonist in MPTP-treated monkeys

1999 • 249 citations

Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium

1986 • 241 citations

MPTP: current concepts and controversies.

1986 • 234 citations

Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity

1998 • 230 citations

Paralysis agitans of early onset with marked diurnal fluctuation of symptoms

1973 • 227 citations

Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter

1999 • 226 citations

Nicotine Prevents Experimental Parkinsonism in Rodents and Induces Striatal Increase of Neurotrophic Factors

1998 • 218 citations

Aspirin and Salicylate Protect Against MPTP‐Induced Dopamine Depletion in Mice

1998 • 217 citations

Evidence for mitochondrial dysfunction in Parkinson's disease-a critical appraisal

1994 • 216 citations

Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations.

1993 • 209 citations

Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease

1999 • 203 citations

Melatonin is protective against MPTP-induced striatal and hippocampal lesions

1996 • 200 citations

DATATOP: A decade of neuroprotective inquiry

1998 • 198 citations

Neuronal vulnerability in Parkinson’s disease

1997 • 198 citations

A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics.

1983 • 197 citations

Inflammation in Parkinson's disease.

2001 • 195 citations

MPTP

1986 • 193 citations

Oxidative post‐translational modifications of α‐synuclein in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model of Parkinson's disease

2001 • 190 citations

Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

2001 • 182 citations

Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP

1986 • 179 citations

Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins

2001 • 178 citations

Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice

1998 • 177 citations

Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse

1985 • 176 citations

PATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASE

1983 • 168 citations

Ecogenetics of Parkinson's Disease: Prevalence and Environmental Aspects in Rural Areas

1987 • 165 citations

Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization.

1997 • 164 citations

Neurotoxicity at the N‐Methyl‐D‐Aspartate Receptor in Energy‐Compromised Neurons An Hypothesis for Cell Death in Aging and Disease

1989 • 157 citations

DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism.

1998 • 156 citations

Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones

1996 • 148 citations

Enhanced Oxidative Stress and Altered Antioxidants in Brains of Bcl‐2‐Deficient Mice

1998 • 138 citations

Low frequency of α‐synuclein mutations in familial Parkinson's disease

1998 • 137 citations

Dopamine Neurons from Transgenic Mice with a Knockout of the p53 Gene Resist MPTP Neurotoxicity

1996 • 135 citations

MPTP: A neurotoxin producing a parkinsonian syndrome

1987 • 133 citations

Neurotoxicity of levodopa on catecholamine‐rich neurons

1992 • 133 citations

Sensitivity to MPTP is not increased in Parkinson's disease‐associated mutant α‐synuclein transgenic mice

2001 • 127 citations

Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment

1986 • 125 citations

Evidence for neuromelanin involvement in MPTP-induced neurotoxicity

1987 • 120 citations

In Vivo Generation of Hydroxyl Radicals and MPTP‐Induced Dopaminergic Toxicity in the Basal Ganglia

1994 • 118 citations

Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson’s disease

1998 • 118 citations

Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.

1991 • 115 citations

Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease

1999 • 114 citations

Mice with a Partial Deficiency of Manganese Superoxide Dismutase Show Increased Vulnerability to the Mitochondrial Toxins Malonate, 3-Nitropropionic Acid, and MPTP

2001 • 114 citations

The Neurobiology of Dopamine

1980 • 113 citations

Peptides and Parkinson's disease

1985 • 112 citations

Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins

1998 • 112 citations

The Antioxidant Ebselen Prevents Neurotoxicity and Clinical Symptoms in a Primate Model of Parkinson's Disease

2000 • 108 citations

The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase

1987 • 107 citations

Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.

1987 • 101 citations

Preservation of hypothalamic dopaminergic neurons in Parkinson's disease

1985 • 101 citations

Brain dialysis in conscious rats reveals an instantaneous massive release striatal dopamine in response to MPP+

1986 • 99 citations

Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice

1994 • 98 citations

Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice

1996 • 98 citations

Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

2001 • 97 citations

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease.

1996 • 94 citations

Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats

1998 • 91 citations

Smoking and Parkinson's disease: a case-control study in Germany

1997 • 91 citations

Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity

1991 • 90 citations

Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

2001 • 87 citations

Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.

2000 • 86 citations

Imaging the vesicular monoamine transporter.

2001 • 85 citations

S-Methylthiocitrulline, a Neuronal Nitric Oxide Synthase Inhibitor, Protects against Malonate and MPTP Neurotoxicity

1997 • 81 citations

Reduced expression of the G209A ?-synuclein allele in familial parkinsonism

1999 • 80 citations

Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)

1985 • 78 citations

Inhibition of ATP synthesis by 1-methyl-4-phenylpyridinium ion (MPP+) in isolated mitochondria from mouse brains

1987 • 74 citations

Familial Parkinson's disease. Alpha-synuclein and parkin.

2001 • 73 citations

Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease

1998 • 72 citations

Paraquat: A Useful Tool for the in vivo Study of Mechanisms of Neuronal Cell Death

1998 • 72 citations

Monoamine oxidase and oxidative stress at dopaminergic synapses

1990 • 71 citations

Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources

1985 • 71 citations

cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson’s disease

2000 • 69 citations

In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.

2000 • 64 citations

Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from Tobacco

2001 • 58 citations

The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter

1998 • 58 citations

1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine (2′-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in mice

1986 • 56 citations

Parkinson's disease. The apoptosis hypothesis revisited.

2001 • 55 citations

Free radical scavengers: chemical concepts and clinical relevance

1999 • 54 citations

The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease

1994 • 52 citations

Strain‐dependent susceptibility to MPTP and MPP⁺‐induced Parkinsonism is determined by glia

2001 • 51 citations

The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetra-hydropyridine (MPTP) to Parkinson's disease

1984 • 51 citations

Parkinson’s disease — a multifactorial neurodegenerative disorder

1999 • 51 citations

Cell death induced by MPTP, a substrate for monoamine oxidase B

2000 • 49 citations

In Brown Norway Rats, MPP+ Is Accumulated in the Nigrostriatal Dopaminergic Terminals but It Is Not Neurotoxic: A Model of Natural Resistance to MPTP Toxicity

1994 • 48 citations

Parkinson's disease is not one disease

2000 • 46 citations

Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release

2000 • 44 citations

Pesticides and Parkinsonism: is there an etiological link?

2000 • 42 citations

Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism

1999 • 39 citations

Molecular Mechanisms of Neurodegenerative Diseases

2000 • 39 citations

SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

2001 • 38 citations

Discussion

1998 • 38 citations

In vivo imaging of monoaminergic nerve terminals in normal and MPTP‐lesioned primate brain using positron emission tomography (PET) and [¹¹C]tetrabenazine

1993 • 38 citations

Deprenyl and tocopherol antioxidative therapy of parkinsonism (DATATOP)

1989 • 37 citations

Is Parkinson’s Disease Acquired or Inherited?

1984 • 37 citations

Genetic polymorphisms in Parkinson's disease.

1998 • 37 citations

Novel Free Radical Spin Traps Protect against Malonate and MPTP Neurotoxicity

1999 • 34 citations

The N-Methyl-D-Aspartate Antagonist MK-801 Fails to Protect Dopaminergic Neurons from 1-Methyl-4- Phenylpyridinium Toxicity In Vitro

1993 • 29 citations

Relationship of Complement-Activated Oligodendrocytes to Reactive Microglia and Neuronal Pathology in Neurodegenerative Disease

1991 • 28 citations

The Protective Effects of PBN Against MPTP Toxicity Are Independent of Hydroxyl Radical Trapping

2000 • 25 citations

Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components

1992 • 24 citations

The Role of Iron in Parkinson Disease and 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Toxicity

1999 • 24 citations

N,N'-Bis-Dibenzyl Ethylenediaminediacetic Acid (Dbed): a Site-Specific Hydroxyl Radical Scavenger Acting as an “Oxidative Stress Activatable” Iron ChelatorIn Vitro

1995 • 23 citations

Molecular genetics of Parkinson's disease.

2001 • 20 citations

Is there neuroprotection in Parkinson syndrome?

2000 • 18 citations

Participation of manganese-superoxide dismutase in the neuroprotection exerted by copper sulfate against 1-methyl 4-phenylpyridinium neurotoxicity

2001 • 16 citations

Dopamine agonists. Their role in the management of Parkinson's disease.

2001 • 14 citations

Further studies in xenobiotic metabolism and Parkinson's disease.

2001 • 8 citations

Mitochondria and Parkinson's Disease

2011 • 8 citations

Neurochemical and neuroreceptor imaging with PET in Parkinson's disease.

2001 • 7 citations

Pathogenesis of Neurodegenerative Disorders

2002 • 2 citations

Introduction: Targeted Modulation of Neuronal Apoptosis: A Double‐Edged Sword?

2000 • 2 citations

Parkinson's disease (advances in neurology, volume 69

1996 • 1 citations

[Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism].

1989 • 1 citations

Tau and α-Synuclein in Neurodegenerative Diseases

2001 • 1 citations

Deleted Work

1955 • 0 citations